DeutschNewstral
Article
jdsupra.com on 2024-02-27 20:59
DOJ Renews Focus on Private Equity Amid Record False Claims Act Enforcement
Related news
- Déjà Vu All Over Again: Pandemic Renews Focus on Ongoing False Claims Act Enforcement Prioritiesjdsupra.com
- DOJ Renews Commitment to Immigration Enforcementjdsupra.com
- Government Contracts Enforcement: DOJ Publishes FY 2023 False Claims Act Statisticsjdsupra.com
- DOJ Announces New Cyber-Fraud Initiative Promoting False Claims Act Enforcement Against Contractors and Grantees Failing to Follow Cybersecurity Standardsjdsupra.com
- DOJ Adds Private Equity Firm To False Claims Act Complaintjdsupra.com
- DOJ Targeting Private Equity Firms in False Claims Act Litigationjdsupra.com
- DOJ Antitrust Head Signals Aggressive Enforcement against Private Equity Transactionsjdsupra.com
- DOJ Continues False Claims Act Enforcement in Transportation Industryjdsupra.com
- DOJ Leverages the Private Sector To Achieve Enforcement Goalsjdsupra.com
- Enforcement Update – DOJ Raises Focus on Prosecuting Individualsjdsupra.com
- Will There Be a New Wave of Federal White Collar Crime Enforcement? DOJ Announces Its New Priorities to Focus on Combatting Corporate Wrongdoingjdsupra.com
- DOJ Intervenes in False Claims Act Case Against a Compounding Pharmacy and Private Equity Firmjdsupra.com
- DOJ Provides Guidelines for Reducing False Claims Act Settlements through Cooperation - Government Enforcement Updatejdsupra.com
- Congress Renews Push on Investigating Private Equity Investment in Healthcarejdsupra.com
- DOJ Announces Renewed Focus on Corporate Crimejdsupra.com
- DOJ Complaint Names Private Equity Firm as Defendant in False Claims Act Case Targeting Health Care Portfolio Companyjdsupra.com
- DOJ-Initiated False Claims Act Cases Reached Record High in Fiscal Year 2023jdsupra.com
- “Sanctions Are The New FCPA”: DOJ Increases Focus on Sanctions and Export Control Enforcementjdsupra.com
- Sanctions are “the New FCPA”: A Heightened Focus for DOJ Enforcementjdsupra.com
- “A Prescription for Competition”: DOJ Antitrust Division Affirms Its Enforcement Focus on the Healthcare Industryjdsupra.com